NICOSIA, CYPRUS, June 04, 2011 (Press-News.org) Due to increasing international demand, MedWOW greatly expanded its operations by launching a Global Franchise Program. MedWOW's Franchise Program screens qualified medical equipment professionals throughout the world, in order to find the best representatives to join the MedWOW brand and offer the website's services in their defined territory.
The franchise program offers reputable key-players in the medical equipment industry the opportunity to expand their existing business, by giving them the rights to market MedWOW to end-users in their territories, including: hospitals, laboratories, private clinics, dental clinics, veterinary centers, and other healthcare settings.
In order to increase the scope of the Franchise Network, while strengthening the important relationship between the MedWOW home office and existing franchisees, 2 new franchise management professionals have been added to the team: Ms. Lorren Katz and Mr. Michael Kasan.
Mr. Kasan, the new Franchise Manager, has over 10 years experience in franchise and channel management in the international market and worked in several B2B companies. He has earned an MBA, a BA in life sciences and is a licensed medic.
Ms. Katz comes from an extensive background in various aspects of the medical field for over 15 years, and has done medical transcriptions and reports. Katz will be assisting Kasan with the Franchisee Management and will be dealing exclusively with the Franchisees to help in ensuring optimal performance, lucrative business practices and maximizing marketing exposure in each particular local market.
MedWOW's new Franchise Manager commented: "We are currently focused on adding new franchises, but it is equally important to us to make sure the existing franchisees throughout the world, with their diverse backgrounds and cultural specifications, receive the proper tools for maximizing success. We are developing new tools, as well as upgrading advertising and marketing strategies, to ensure that they meet all their goals."
Learn more about MedWOW's Franchise Program.
MedWOW.com is the leading international, online marketplace for buying and selling new and used medical equipment. The user-friendly website connects buyers, sellers and service providers of medical equipment from all over the world by offering: comprehensive professional services, unprecedented reliability, multilingual customer support and top value.
Website: http://www.medwow.com
MedWOW's Global Medical Eqiupment Platform Strengthens Franchise Team
MedWOW has added two key players to the Franchise Team Management, strengthening the relationships between the home office and their established international franchisees.
2011-06-04
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Study links empathy, self-esteem, and autonomy with increased sexual enjoyment
2011-06-04
Sexual pleasure among young adults (ages 18-26) is linked to healthy psychological and social development, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health. The study is the first to use a representative population sample of heterosexuals to find a relationship between key developmental assets and sexual pleasure. The findings are published in the June 2011 issue of The Journal of Adolescent Health.
The research study examined data from 3,237 respondents ages 18 to 26 from the National Longitudinal Study of Adolescent Health, ...
NIH scientists reactivate immune cells exhausted by chronic HIV
2011-06-04
Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have demonstrated why certain immune cells chronically exposed to HIV shut down, and how they can be reactivated.
Healthy B cells have a balanced mix of surface proteins that the immune system can use, like the gas pedal and brake of a car, either to activate the cell or to damp down its activity. However, in people with long-term HIV infection who have not begun antiretroviral therapy, their B cells—responsible for producing anti-HIV antibodies—display ...
USC researchers discover genetic mutation causing excessive hair growth
2011-06-04
Los Angeles, Calif., June 2, 2011—Researchers in the Keck School of Medicine of the University of Southern California (USC), together with scientists in Beijing, China, have discovered a chromosomal mutation responsible for a very rare condition in which people grow excess hair all over their bodies. Investigators hope the finding ultimately will lead to new treatments for this and less severe forms of excessive hair growth as well as baldness.
The study, "X-linked congenital hypertrichosis syndrome is associated with interchromosomal insertions mediated by a human-specific ...
Matching targeted therapies to tumor's specific gene mutations key to personalized cancer treatment
2011-06-04
CHICAGO — Customizing targeted therapies to each tumor's molecular characteristics, instead of a one-size-fits-all approach by tumor type, may be more effective for some types of cancer, according to research conducted by The University of Texas MD Anderson Cancer Center.
MD Anderson's Phase I findings were presented today on the opening press program of the 47th Annual Meeting of the American Society of Clinical Oncology. Apostolia-Maria Tsimberidou, M.D., Ph.D., associate professor in MD Anderson's Department of Investigational Cancer Therapeutics, and the study's principal ...
Benefit of targeted lung cancer therapy confirmed
2011-06-04
AURORA, Colo. (June 3, 2011) – A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and the results from the largest group of patients to take it within the first of these clinical trials are being presented at the annual meeting of the American Society of Clinical Oncology (ASCO).
The patients taking crizotinib have anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC) and the drug targets the gene ...
Vaccine first to show improved survival rates for metastatic melanoma
2011-06-04
(CHICAGO) – For patients with advanced melanoma, which is the most lethal type of skin cancer, the results of a large clinical trial show that a vaccine combined with the immune-boosting drug Interleukin-2 can improve response rate and progression-free survival.
The findings of the study were published in the June 2 issue of New England Journal of Medicine. This marks the first vaccine study in the disease and one of the first in all cancers to show clinical benefit in a randomized Phase III clinical trial.
"This is the first time that a vaccine has shown benefit ...
Cancer survivors can't shake pain, fatigue, insomnia, foggy brain
2011-06-04
CHICAGO --- When people finish treatment for cancer, they want to bounce back to their former vital selves as quickly as possible. But a new Northwestern Medicine study -- one of the largest survivor studies ever conducted – shows many survivors still suffer moderate to severe problems with pain, fatigue, sleep, memory and concentration three to five years after treatment has ended.
"We were surprised to see how prevalent these symptoms still are," said study co-investigator Lynne Wagner, an associate professor of medical social sciences at Northwestern University Feinberg ...
River mystery solved
2011-06-04
The pristine state of unpolluted waterways may be their downfall, according to research results published in a paper this week in the journal Geophysical Research Letters.
A species of freshwater algae that lives in streams and rivers, called Didymo for Didymosphenia geminata, is able to colonize and dominate the bottoms of some of the world's cleanest waterways--precisely because they are so clear.
Didymo does so with a little help from its friends--in this case, bacteria--which allow it to make use of nutrients like phosphorus.
Blooms of Didymo, also known as "rock ...
Maple Online Casino Makes Big Winners
2011-06-04
Malta - May 2011 - Celebrations are certainly underway in D. R.'s household today, because he has just won over $82,000 playing at Maple Online Casino. He won a few prizes while playing different games, which makes his winnings even more impressive.
D. R. won $61,522.00 while playing Hitman; $12,050.00 on Multi-Hand European Blackjack; and $9,350.00 while playing Classic Blackjack. Thus, all his winnings for the day equal $82,922.00.
Casino Manager, Charlotte Jackson, was available for comment. "Congratulations D. R. We are very proud of your accomplishments ...
Mayo Clinic, NCCTG find no tie between PTEN and response to breast cancer drug
2011-06-04
CHICAGO -- ASCO Abstract #10504. Contrary to what many oncologists had thought, a tumor suppressor protein known as PTEN does not reduce the effectiveness of the breast cancer drug Herceptin, according to a study by Mayo Clinic and North Central Cancer Research Group (NCCTG) investigators. The study, which looked at tumors from 1,802 patients enrolled in the NCCTG N9831 clinical trial, found that patients with HER2-positive breast cancer and had either a loss of PTEN functioning or normal PTEN activity did equally well when Herceptin was added to chemotherapy to prevent ...
LAST 30 PRESS RELEASES:
Brain waves’ analog organization of cortex enables cognition and consciousness, MIT professor proposes at SfN
Low-glutamate diet linked to brain changes and migraine relief in veterans with Gulf War Illness
AMP 2025 press materials available
New genetic test targets elusive cause of rare movement disorder
A fast and high-precision satellite-ground synchronization technology in satellite beam hopping communication
What can polymers teach us about curing Alzheimer's disease?
Lead-free alternative discovered for essential electronics component
BioCompNet: a deep learning workflow enabling automated body composition analysis toward precision management of cardiometabolic disorders
Skin cancer cluster found in 15 Pennsylvania counties with or near farmland
For platforms using gig workers, bonuses can be a double-edged sword
Chang'e-6 samples reveal first evidence of impact-formed hematite and maghemite on the Moon
New study reveals key role of inflammasome in male-biased periodontitis
MD Anderson publicly launches $2.5 billion philanthropic campaign, Only Possible Here, The Campaign to End Cancer
Donors enable record pool of TPDA Awards to Neuroscience 2025
Society for Neuroscience announces Gold Sponsors of Neuroscience 2025
The world’s oldest RNA extracted from woolly mammoth
Research alert: When life imitates art: Google searches for anxiety drug spike during run of The White Lotus TV show
Reading a quantum clock costs more energy than running it, study finds
Early MMR vaccine adoption during the 2025 Texas measles outbreak
Traces of bacteria inside brain tumors may affect tumor behavior
Hypertension affects the brain much earlier than expected
Nonlinear association between systemic immune-inflammation index and in-hospital mortality in critically ill patients with chronic obstructive pulmonary disease and atrial fibrillation: a cross-sectio
Drift logs destroying intertidal ecosystems
New test could speed detection of three serious regional fungal infections
New research on AI as a diagnostic tool to be featured at AMP 2025
New test could allow for more accurate Lyme disease diagnosis
New genetic tool reveals chromosome changes linked to pregnancy loss
New research in blood cancer diagnostics to be featured at AMP 2025
Analysis reveals that imaging is overused in diagnosing and managing the facial paralysis disorder Bell’s palsy
Research progress on leptin in metabolic dysfunction-associated fatty liver disease
[Press-News.org] MedWOW's Global Medical Eqiupment Platform Strengthens Franchise TeamMedWOW has added two key players to the Franchise Team Management, strengthening the relationships between the home office and their established international franchisees.